Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Healthcare Services Industry Analysis

UpdatedJan 24, 2026
DataAggregated Company Financials
Companies9
  • 7D-0.3%
  • 3M-9.4%
  • 1Y15.9%
  • YTD-1.6%

Over the last 7 days, the Healthcare Services industry has remained flat, although notably Attendo gained 4.9%. The past year has been better, since the industry has gained 15% in that time. Earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the Swedish Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 Jan 2026SEK 90.0bSEK 88.6bSEK 2.9b19.4x31.2x1x
Mon, 22 Dec 2025SEK 61.3bSEK 72.8bSEK 2.4b17.7x25.8x0.8x
Wed, 19 Nov 2025SEK 61.7bSEK 73.1bSEK 2.4b16.8x25.9x0.8x
Fri, 17 Oct 2025SEK 63.6bSEK 72.3bSEK 2.0b17.1x32.6x0.9x
Sun, 14 Sep 2025SEK 66.4bSEK 72.1bSEK 2.0b18.1x34x0.9x
Tue, 12 Aug 2025SEK 65.9bSEK 72.1bSEK 1.9b16.9x34.6x0.9x
Thu, 10 Jul 2025SEK 62.9bSEK 71.3bSEK 1.7b16.7x36.9x0.9x
Sat, 07 Jun 2025SEK 58.9bSEK 71.0bSEK 1.7b15.8x34.7x0.8x
Mon, 05 May 2025SEK 60.6bSEK 70.3bSEK 1.6b18.6x37.6x0.9x
Wed, 02 Apr 2025SEK 84.9bSEK 84.1bSEK 1.8b20.5x48.2x1x
Fri, 28 Feb 2025SEK 55.2bSEK 69.8bSEK 1.4b19x39.3x0.8x
Sun, 26 Jan 2025SEK 51.7bSEK 68.5bSEK 1.4b17.2x37.7x0.8x
Tue, 24 Dec 2024SEK 49.5bSEK 68.5bSEK 1.4b17x36.1x0.7x
Thu, 21 Nov 2024SEK 45.7bSEK 68.8bSEK 1.4b16.9x33.3x0.7x
Sat, 19 Oct 2024SEK 48.3bSEK 66.7bSEK 1.2b18.9x38.8x0.7x
Mon, 16 Sep 2024SEK 49.1bSEK 66.5bSEK 1.2b18.9x39.6x0.7x
Wed, 14 Aug 2024SEK 45.5bSEK 66.7bSEK 1.2b14.4x37.9x0.7x
Fri, 12 Jul 2024SEK 47.8bSEK 64.9bSEK 1.3b14.1x36.7x0.7x
Sun, 09 Jun 2024SEK 47.1bSEK 64.9bSEK 1.3b14.6x36.2x0.7x
Tue, 07 May 2024SEK 43.7bSEK 65.4bSEK 1.3b12x33.3x0.7x
Thu, 04 Apr 2024SEK 36.6bSEK 63.9bSEK 1.2b12.8x29.8x0.6x
Sat, 02 Mar 2024SEK 36.2bSEK 63.3bSEK 1.2b12.2x29.6x0.6x
Mon, 29 Jan 2024SEK 39.9bSEK 62.0bSEK 941.0m13.2x42.4x0.6x
Wed, 27 Dec 2023SEK 36.7bSEK 61.5bSEK 938.4m13.6x39.1x0.6x
Fri, 24 Nov 2023SEK 35.7bSEK 62.2bSEK 949.5m12.5x37.6x0.6x
Sun, 22 Oct 2023SEK 29.6bSEK 60.6bSEK 904.2m10.7x32.7x0.5x
Tue, 19 Sep 2023SEK 32.3bSEK 61.0bSEK 905.6m9.3x35.6x0.5x
Thu, 17 Aug 2023SEK 34.7bSEK 60.7bSEK 945.2m8.3x36.7x0.6x
Sat, 15 Jul 2023SEK 35.5bSEK 58.5bSEK 766.4m8.9x46.3x0.6x
Mon, 12 Jun 2023SEK 36.9bSEK 58.6bSEK 768.6m10.1x48x0.6x
Wed, 10 May 2023SEK 38.0bSEK 58.0bSEK 766.0m11.1x49.6x0.7x
Fri, 07 Apr 2023SEK 37.8bSEK 56.6bSEK 791.7m15.8x47.7x0.7x
Sun, 05 Mar 2023SEK 37.7bSEK 56.4bSEK 797.2m14x47.3x0.7x
Tue, 31 Jan 2023SEK 39.3bSEK 55.1bSEK 1.0b12.9x37.9x0.7x
Price to Earnings Ratio

37.9x


Total Market Cap: SEK 39.3bTotal Earnings: SEK 1.0bTotal Revenue: SEK 55.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthcare Services Industry Price to Earnings3Y Average 36.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 31.2x which is lower than its 3-year average PE of 36.9x.
  • The 3-year average PS ratio of 0.71x is lower than the industry's current PS ratio of 1.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 41% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-1.18%
Healthcare-1.53%
Healthcare Services-0.26%
Healthcare Facilities2.42%
Healthcare Distributors0.38%
Healthcare Services-3.05%
Industry PE
  • Investors are most optimistic about the Healthcare Distributors industry which is trading above its 3-year average PE ratio of 50.2x.
    • Analysts expect its future annual earnings growth (27.3%) to be largely in line with prior year's earnings growth.
  • Investors are most pessimistic about the Healthcare Facilities industry, which is trading close to its 3-year average of 15.2x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Distributors industry, expecting annual earnings growth of 27% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Healthcare Facilities industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ATT AttendoSEK 88.104.9%
+SEK 579.9m		71.1%PE19.4x
ASKER Asker Healthcare GroupSEK 79.060.4%
+SEK 134.1m		n/aPE57.2x
AMBEA AmbeaSEK 134.400.1%
+SEK 16.8m		44.9%PE16.5x
HUM HumanaSEK 51.000.6%
+SEK 14.8m		45.5%PE10.5x
HEGR Hedera GroupSEK 0.681.5%
+SEK 341.7k		-85.9%PS0.05x

Latest News

ATT
SEK 88.10
Attendo
7D
4.9%
1Y
71.1%

Is Now The Time To Put Attendo (STO:ATT) On Your Watchlist?

Jan 23
Is Now The Time To Put Attendo (STO:ATT) On Your Watchlist?
NGS
SEK 2.31
NGS Group
7D
-4.1%
1Y
-25.0%

NGS Group (NGM:NGS) Takes On Some Risk With Its Use Of Debt

Jan 23
NGS Group (NGM:NGS) Takes On Some Risk With Its Use Of Debt
HUM
SEK 51.00
Humana
7D
0.6%
1Y
45.5%

HUM: Stable Assumptions And Minor Model Tweaks Will Support Stronger Future Share Performance

Analysts have adjusted their price target on Humana upward to reflect a fair value of $60.00, citing only minor tweaks to discount rate, revenue growth, profit margin, and future P/E assumptions, rather than any major shift in the core outlook. Valuation Changes Fair Value: Kept steady at US$60.00 per share, with no change in the stated target level.
AMBEA
SEK 134.40
Ambea
7D
0.1%
1Y
44.9%

Is Ambea (STO:AMBEA) A Risky Investment?

Jan 15
Is Ambea (STO:AMBEA) A Risky Investment?
EQL
SEK 56.90
EQL Pharma
7D
-0.7%
1Y
-28.7%

EQL: Future UTI Prophylaxis Launch In Germany Will Drive Upside

Analysts have maintained their price target on EQL Pharma at SEK 80.00, citing consistent assumptions for the discount rate, revenue growth, profit margin and future P/E that support keeping the previous fair value assessment unchanged. What's in the News EQL Pharma has called a special/extraordinary shareholders meeting for February 3, 2026, at 13:00 W.
MCOV B
SEK 205.00
Medicover
7D
-3.1%
1Y
-1.2%

MCOV B: MRD Study Progress Will Support Balanced Long Term Prospects

Analysts have lifted their price target on Medicover to €230.73 per share, reflecting updated assumptions that combine a higher revenue growth outlook of 13.50% with a slightly lower profit margin of 4.09% and a modestly higher future P/E of 27.52x. What's in the News Additional results from the ongoing DART clinical study using Medicover Genetics' hybrid capture based, tumour agnostic MRD assay were presented at the European Society for Medical Oncology Congress in Berlin on 18 October 2025.
ASKER
SEK 79.06
Asker Healthcare Group
7D
0.4%
1Y
n/a
HEGR
SEK 0.68
Hedera Group
7D
1.5%
1Y
-85.9%
DEDI
SEK 42.80
Dedicare
7D
-1.4%
1Y
-31.3%